Biomarker Development/Validation (2021)
| קרן | ALS Association |
|---|---|
| מדינה | U.S.A. |
| סוג | Research Grants |
| תאריך אחרון | 07/05/2021 |
| פקולטה | Life Sciences, Medicine |
| תיאור | This RFA aims to support the discovery and/or validation of biomarkers for ALS or a related disorder (including primary lateral sclerosis [PLS], hereditary spastic paraplegia [HSP], progressive muscular atrophy [PMA], multisystem proteinopathy [MSP], and frontotemporal dementia [FTD]). Priority will be given to those projects that are focused on developing biomarkers of disease mechanism and that might be relevant to the development of therapies.
Funding: $60,000 total Duration: 1 year
Research Authority due date: 29.4.21 LOI (required) due date: 7.5.21 Full proposal due date: 30.7.21 |
| קבצים מצורפים | |
| קישור | לאתר |
| עדכון אחרון | עדכון אחרון: 13/04/2021 |
